News

Permission was obtained to conduct a study of the safety and effectiveness of a tuberculosis recombinant vaccine in relation to preventing the development of primary lung tuberculosis

The sponsor's approval was received for the site`s participation in a new clinical trial of a drug for the biological therapy of severe eosinophilic bronchial asthma, conducted by the pharmaceutical company GSK

The site's participation in the GSK clinical trial has been approved by the sponsor. The aim of the study is to evaluate the efficacy and safety of a new drug for the treatment of spondyloarthritis, refractory to other types of therapy

New pulmonological protocols: participation in the study of a new therapy for chronic refractory cough is proposed